Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAWN-PLASMA: Convalescent Plasma for COVID-19
NCT04429854Phase 2Completed
- Sponsor
- UZ Leuven
- Start
- May 2020
- Primary completion
- Apr 2021
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of convalescent plasma (Heinrich-Heine University, Duesseldorf) in coronavirus disease 2019 (COVID-19), sponsored by UZ Leuven. Started May 2020; status: completed.
02
Drugs
convalescent plasma (Heinrich-Heine University, Duesseldorf)
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04429854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04429854.